HIV contains genetic information that directs the production of viral proteins and supports its replication. The virus primarily targets CD4 T lymphocytes, although other immune system cells can also be involved. Its genetic material is enclosed within a protective structure and surrounded by a lipid envelope containing viral proteins that help it attach to host cells.
The HIV genome includes several important genes that contribute to viral structure, enzyme production, and infection processes.
HIV genetic variation develops through replication errors and other biological processes. These changes can produce different viral variants and influence their characteristics.
HIV replication involves a sequence of molecular events that begins when the virus enters a susceptible host cell. The viral genome is converted from RNA into DNA, and the resulting DNA is integrated into the host cell's genetic material. This integrated viral DNA, known as a provirus, can direct the production of viral RNA and proteins.
The major stages of HIV replication include:
Reverse transcriptase, integrase, and protease are essential enzymes involved in different stages of the HIV life cycle. Their functions are important areas of molecular research because changes in their activity can affect viral replication.
HIV replication can introduce genetic changes because reverse transcriptase has limited proofreading capability. Some genetic variations may affect viral characteristics or reduce susceptibility to particular antiretroviral medicines. Researchers study these changes to understand viral evolution and treatment resistance.
Understanding HIV molecular biology provides a scientific foundation for studying viral infection, genetic replication, and the mechanisms of antiretroviral medicines. Research into viral enzymes, host cell interactions, and genetic variation continues to support advances in HIV prevention and treatment.